1-6 of 6
Charles Swanton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion

Fabio Conforti, Laura Pala, Eleonora Pagan, Vincenzo Bagnardi, Tommaso De Pas, Paola Queirolo, Elisabetta Pennacchioli, Chiara Catania, Emilia Cocorocchio, Pier Francesco Ferrucci, Maristella Saponara, Gianmarco Orsolini, Paola Zagami, Eleonora Nicoló, Filippo De Marinis, Giampaolo Tortora, Emilio Bria, Saverio Minucci, Hadine Joffe, Paolo Veronesi, Jennifer Wargo, Rachel Rosenthal, Charles Swanton, Alberto Mantovani, Richard D. Gelber, Giuseppe Viale, Aron Goldhirsch, Giuseppe Giaccone
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (15): 4311–4324.
https://doi.org/10.1158/1078-0432.CCR-21-0136
Published: 01 August 2021
View article titled, Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion
Open the PDF for Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion in another window
Includes: Supplementary data
Journal Articles

Abstract S12-02: Comprehensive meta-analysis of COVID-19 mortality rates for 22 cancer subtypes from the Reboot: COVID-Cancer Project, an interactive resource with aggregated data from 21,839 cancer patients

Emily-Claire Duffy, Kelly Fan, Shailesh Advani, Chris Bailey, James R.M. Black, Ellie Strauss, Devon Crittenden, Thomas Bhangdia, Allyson Imbacuan, Emily Yang, Allison Britt, Pradeep Mangalath, Charles Swanton, Laura B. Kleiman, Catherine Del Vecchio Fitz
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (6_Supplement): S12-02.
https://doi.org/10.1158/1557-3265.COVID-19-21-S12-02
Published: 15 March 2021
View article titled, Abstract S12-02: Comprehensive meta-analysis of COVID-19 mortality rates for 22 cancer subtypes from the Reboot: COVID-Cancer Project, an interactive resource with aggregated data from 21,839 cancer patients
Journal Articles

Abstract IA23: Allele-specific HLA loss and immune escape in lung cancer evolution

Nicholas McGranahan, Rachel Rosenthal, Crispin T. Hiley, Andrew J. Rowan, Thomas B.K. Watkins, Gareth A. Wilson, Nicolai J. Birkbak, Selvaraju Veeriah, Peter Van Loo, Javier Herrero, Charles Swanton
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (17_Supplement): IA23.
https://doi.org/10.1158/1557-3265.AACRIASLC18-IA23
Published: 01 September 2018
View article titled, Abstract IA23: Allele-specific HLA loss and immune escape in lung cancer evolution
Journal Articles

Translational Implications of Tumor Heterogeneity

Mariam Jamal-Hanjani, Sergio A. Quezada, James Larkin, Charles Swanton
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (6): 1258–1266.
https://doi.org/10.1158/1078-0432.CCR-14-1429
Published: 12 March 2015
View article titled, Translational Implications of Tumor Heterogeneity
Open the PDF for Translational Implications of Tumor Heterogeneity in another window
Journal Articles

89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients

Sietske B.M. Gaykema, Carolien P. Schröder, Joanna Vitfell-Rasmussen, Sue Chua, Thijs H. Oude Munnink, Adrienne H. Brouwers, Alfons H.H. Bongaerts, Mikhail Akimov, Cristina Fernandez-Ibarra, Marjolijn N. Lub-de Hooge, Elisabeth G.E. de Vries, Charles Swanton, Udai Banerji
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (15): 3945–3954.
https://doi.org/10.1158/1078-0432.CCR-14-0491
Published: 31 July 2014
View article titled, <sup>89</sup>Zr-trastuzumab and <sup>89</sup>Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients
Open the PDF for <sup>89</sup>Zr-trastuzumab and <sup>89</sup>Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Her2-Targeted Therapies in Non–Small Cell Lung Cancer

Charles Swanton, Andy Futreal, Tim Eisen
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4377s–4383s.
https://doi.org/10.1158/1078-0432.CCR-06-0115
Published: 20 July 2006
View article titled, Her2-Targeted Therapies in Non–Small Cell Lung Cancer
Open the PDF for Her2-Targeted Therapies in Non–Small Cell Lung Cancer in another window